Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ARDX

Ardelyx

$6.26

0.47 (8.12%)

07:22
09/13/19
09/13
07:22
09/13/19
07:22
Conference/Events
Ardelyx management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

Thursday
ARDX

Ardelyx

$5.71

-0.08 (-1.38%)

15:42
09/12/19
09/12
15:42
09/12/19
15:42
Hot Stocks
Breaking Hot Stocks news story on Ardelyx »

Ardelyx up 13.5% to $6.58…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$5.71

-0.08 (-1.38%)

15:40
09/12/19
09/12
15:40
09/12/19
15:40
Hot Stocks
Breaking Hot Stocks news story on Ardelyx 

Ardelyx trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$5.71

-0.08 (-1.38%)

15:34
09/12/19
09/12
15:34
09/12/19
15:34
Recommendations
Ardelyx analyst commentary at Piper Jaffray »

Piper says Ardelyx IBS-C…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$5.71

-0.08 (-1.38%)

15:27
09/12/19
09/12
15:27
09/12/19
15:27
Hot Stocks
Ardelyx says Ibsrela prescribing information includes Box Warning »

Ardelyx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$5.71

-0.08 (-1.38%)

15:14
09/12/19
09/12
15:14
09/12/19
15:14
Hot Stocks
Ardelyx receives FDA approval for Ibsrela »

Ardelyx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$6.14

0.35 (6.04%)

14:39
09/12/19
09/12
14:39
09/12/19
14:39
Hot Stocks
Breaking Hot Stocks news story on Ardelyx »

Ardelyx trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$6.16

0.37 (6.39%)

14:36
09/12/19
09/12
14:36
09/12/19
14:36
Hot Stocks
Breaking Hot Stocks news story on Ardelyx 

Ardelyx trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$6.16

0.37 (6.39%)

14:34
09/12/19
09/12
14:34
09/12/19
14:34
Hot Stocks
Ardelyx new drug application for tenapanor granted FDA approval 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

ARDX

Ardelyx

$6.15

0.36 (6.22%)

14:31
09/12/19
09/12
14:31
09/12/19
14:31
Hot Stocks
Breaking Hot Stocks news story on Ardelyx »

Ardelyx trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.